A detailed history of Andra Ap Fonden transactions in Abbott Laboratories stock. As of the latest transaction made, Andra Ap Fonden holds 69,608 shares of ABT stock, worth $7.99 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
69,608
Previous 86,508 19.54%
Holding current value
$7.99 Million
Previous $8.99 Million 11.71%
% of portfolio
0.12%
Previous 0.15%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $1.69 Million - $2 Million
-16,900 Reduced 19.54%
69,608 $7.94 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $1.15 Million - $1.28 Million
11,400 Added 15.18%
86,508 $8.99 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $8.23 Million - $9.09 Million
75,108 New
75,108 $8.54 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $1.21 Million - $1.35 Million
-12,000 Reduced 15.64%
64,708 $7.05 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $271,982 - $320,140
2,808 Added 3.8%
76,708 $7.77 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $1.06 Million - $1.25 Million
-11,200 Reduced 13.16%
73,900 $8.11 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.23 Million - $1.42 Million
-12,700 Reduced 12.99%
85,100 $8.23 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $2.63 Million - $3.18 Million
-25,800 Reduced 20.87%
97,800 $10.6 Million
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $1.25 Million - $1.53 Million
-10,800 Reduced 8.04%
123,600 $17.4 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $1.68 Million - $1.86 Million
-14,400 Reduced 9.68%
134,400 $15.9 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $4.88 Million - $5.74 Million
46,100 Added 44.89%
148,800 $17.3 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $152,376 - $179,522
1,400 Added 1.38%
102,700 $12.3 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $2.96 Million - $3.23 Million
28,200 Added 38.58%
101,300 $11.1 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $1.28 Million - $1.56 Million
-14,000 Reduced 16.07%
73,100 $7.96 Million
Q2 2020

Aug 06, 2020

BUY
$76.57 - $98.0 $1.92 Million - $2.46 Million
25,100 Added 40.48%
87,100 $7.96 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $640,764 - $936,972
10,200 Added 19.69%
62,000 $4.89 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $1.49 Million - $1.66 Million
-19,000 Reduced 26.84%
51,800 $4.5 Million
Q3 2019

Nov 19, 2019

SELL
$81.84 - $88.74 $761,112 - $825,282
-9,300 Reduced 11.61%
70,800 $5.92 Million
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $597,616 - $697,000
8,200 Added 11.4%
80,100 $6.74 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $112,574 - $136,102
-1,700 Reduced 2.31%
71,900 $5.75 Million
Q3 2018

Oct 16, 2018

BUY
$60.81 - $73.36 $620,262 - $748,272
10,200 Added 16.09%
73,600 $5.4 Million
Q2 2018

Aug 17, 2018

BUY
$57.57 - $63.54 $1.65 Million - $1.82 Million
28,700 Added 82.71%
63,400 $3.87 Million
Q1 2018

Apr 10, 2018

SELL
$56.27 - $63.62 $10.4 Million - $11.8 Million
-184,800 Reduced 84.19%
34,700 $2.08 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $3.49 Million - $3.74 Million
-65,000 Reduced 22.85%
219,500 $12.5 Million
Q3 2017

Oct 31, 2017

BUY
$48.06 - $53.64 $13.7 Million - $15.3 Million
284,500
284,500 $15.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.